Sort   by:  
 Page size 
UnknownAssociation of intensity of ventilation with 28-day mortality in COVID-19 patients with acute respiratory failure: insights from the PRoVENT-COVID study.
Not available
S-EPMC8343355 | biostudies-literature
UnknownRecalibrating single-study effect sizes using hierarchical Bayesian models.
Not available
S-EPMC10764546 | biostudies-literature
UnknownMapping cortical and subcortical asymmetries in substance dependence: Findings from the ENIGMA Addiction Working Group.
Not available
S-EPMC8317852 | biostudies-literature
UnknownEpidemiology, ventilation management and outcomes of COVID-19 ARDS patients versus patients with ARDS due to pneumonia in the Pre-COVID era.
Not available
S-EPMC11330602 | biostudies-literature
UnknownEfficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.
Not available
S-EPMC5731244 | biostudies-literature
UnknownSubcortical surface morphometry in substance dependence: An ENIGMA addiction working group study.
Not available
S-EPMC7237314 | biostudies-literature
UnknownGenetic imaging consortium for addiction medicine: From neuroimaging to genes.
Not available
S-EPMC4820288 | biostudies-literature
UnknownMega-Analysis of Gray Matter Volume in Substance Dependence: General and Substance-Specific Regional Effects.
Not available
S-EPMC6427822 | biostudies-literature
UnknownRare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19.
Not available
S-EPMC10074346 | biostudies-literature
UnknownInterleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials.
Not available
S-EPMC3827771 | biostudies-literature
Sort   by:  
 Page size